These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10208014)

  • 1. High-density lipoprotein: multipotent effects on cells of the vasculature.
    Cockerill GW; Reed S
    Int Rev Cytol; 1999; 188():257-97. PubMed ID: 10208014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences.
    Francis GA
    Biochim Biophys Acta; 2000 Jan; 1483(2):217-35. PubMed ID: 10634938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
    Tall AR
    J Clin Invest; 1990 Aug; 86(2):379-84. PubMed ID: 2200802
    [No Abstract]   [Full Text] [Related]  

  • 4. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.
    von Eckardstein A; Nofer JR; Assmann G
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):13-27. PubMed ID: 11145929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target.
    Lüscher TF; Landmesser U; von Eckardstein A; Fogelman AM
    Circ Res; 2014 Jan; 114(1):171-82. PubMed ID: 24385510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoproteins and atherosclerosis.
    Betteridge DJ
    Biochem Soc Trans; 1978; 6(5):888-93. PubMed ID: 217757
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of reactive oxygen species in endothelial cells by peroxynitrite-treated lipoproteins.
    Matsunaga T; Nakajima T; Sonoda M; Koyama I; Kawai S; Inoue I; Katayama S; Hirano K; Hokari S; Komoda T
    J Biochem; 2001 Aug; 130(2):285-93. PubMed ID: 11481047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolism of HDL, apo A-I, and lp A-I, and function of HDL--a clinical perspective.
    Zhang B; Saku K; Ohta T
    J Atheroscler Thromb; 2000; 7(2):59-66. PubMed ID: 11426583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL heterogeneity and atherosclerosis.
    Tailleux A; Fruchart JC
    Crit Rev Clin Lab Sci; 1996; 33(3):163-201. PubMed ID: 8828000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
    Tailleux A; Duriez P; Fruchart JC; Clavey V
    Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoproteins in the prevention of atherosclerotic heart disease. Part II. Biochemical role in the pathogenesis of atherosclerosis.
    Berger GM
    S Afr Med J; 1978 Oct; 54(17):693-7. PubMed ID: 217109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins.
    Wolfbauer G; Albers JJ; Oram JF
    Biochim Biophys Acta; 1999 Jul; 1439(1):65-76. PubMed ID: 10395966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages.
    Lin KY; Chen YL; Shih CC; Pan JP; Chan WE; Chiang AN
    J Cell Biochem; 2002; 86(2):258-67. PubMed ID: 12111995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages.
    Rifici VA; Khachadurian AK
    Biochim Biophys Acta; 1996 Jan; 1299(1):87-94. PubMed ID: 8555257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.
    Barter PJ; Baker PW; Rye KA
    Curr Opin Lipidol; 2002 Jun; 13(3):285-8. PubMed ID: 12045398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A receptor-based biosensor for lipoprotein docking at the endothelial surface and vascular matrix.
    Siegel G; Malmsten M; Klüssendorf D; Michel F
    Biosens Bioelectron; 2001 Dec; 16(9-12):895-904. PubMed ID: 11679268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-density lipoproteins: the "new" target of cardiovascular medicine].
    Sampietro T; Bigazzi F; Dal Pino B; Puntoni M; Bionda A
    Ital Heart J Suppl; 2005 Jun; 6(6):341-53. PubMed ID: 16013425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.